BSE Live
Jan 01, 16:00Prev. Close
2.88
Open Price
2.88
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 10, 15:59Prev. Close
4.25
Open Price
4.45
Bid Price (Qty.)
4.25 (475)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Twilight Litaka Pharma (in Rs. Cr.) | Jun 14 | Jun 13 | Mar 12 | Mar 11 | Mar 10 | |
| 12 mths | 15 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 31.46 | 337.19 | 731.78 | 660.25 | 493.90 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.07 | 2.12 | 3.47 | 1.49 | |
| Revenue From Operations [Net] | 31.46 | 337.12 | 729.66 | 656.78 | 492.41 | |
| Total Operating Revenues | 31.50 | 337.50 | 730.19 | 657.34 | 492.41 | |
| Other Income | 0.00 | 0.19 | 1.04 | 3.17 | 2.14 | |
| Total Revenue | 31.51 | 337.69 | 731.23 | 660.51 | 494.55 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 1.16 | 185.42 | 400.55 | 467.21 | 354.79 | |
| Purchase Of Stock-In Trade | 18.74 | 110.92 | 164.03 | 46.44 | 36.91 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 5.03 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 0.00 | 0.21 | -2.77 | -7.78 | -10.07 | |
| Employee Benefit Expenses | 4.81 | 10.13 | 19.99 | 17.68 | 16.01 | |
| Finance Costs | 0.41 | 0.97 | 45.02 | 34.28 | 21.51 | |
| Depreciation And Amortisation Expenses | 4.97 | 6.40 | 5.11 | 3.65 | 3.05 | |
| Other Expenses | 15.55 | 71.97 | 79.84 | 35.65 | 26.85 | |
| Total Expenses | 45.64 | 386.01 | 711.76 | 597.13 | 454.09 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -14.13 | -48.32 | 19.47 | 63.38 | 40.47 | |
| Exceptional Items | -125.45 | -114.40 | -15.03 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | -139.58 | -162.72 | 4.44 | 63.38 | 40.47 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 0.00 | 0.00 | 0.92 | 13.58 | 6.98 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.35 | 0.94 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 0.00 | 0.00 | 0.92 | 13.94 | 7.93 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -139.58 | -162.72 | 3.52 | 49.44 | 32.54 | |
| Profit/Loss From Continuing Operations | -139.58 | -162.72 | 3.52 | 49.44 | 32.63 | |
| Profit/Loss For The Period | -139.58 | -162.72 | 3.52 | 49.44 | 32.63 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | -56.32 | -65.66 | 1.42 | 23.23 | 15.33 | |
| Diluted EPS (Rs.) | -56.32 | -65.66 | 1.42 | 23.23 | 15.33 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.88 | 1.58 | 3.71 | |
| Indigenous Raw Materials | 1.16 | 185.42 | 399.67 | 465.63 | 348.24 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.60 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 3.72 | 3.19 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.62 | 0.53 | |
| Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 30.00 | 30.00 |
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth